| Azhar Shakeel, MD | |
|
Dewey Bartlett & Main, Henryetta, OK 74023-4101 | |
| (918) 650-1323 | |
| (918) 650-1100 |
| Full Name | Azhar Shakeel |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 18 Years |
| Location | Dewey Bartlett & Main, Henryetta, Oklahoma |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114124674 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 25016 (Oklahoma) | Primary |
| Entity Name | Muskogee Medical Care Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629368105 PECOS PAC ID: 8628247012 Enrollment ID: O20110801000243 |
News Archive
A new Wall Street Journal/NBC survey concludes that more Americans than ever before view the health law as a bad idea. Just as these numbers are rolling out, the White House is launching its own messaging effort - reaching out to Democrats and Republicans, high-ranking officials and lawmakers - to get people to sign up for coverage through the overhaul's new online health insurance exchanges.
Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company today announced the resubmission of a New Drug Application (NDA) for the investigational sodium glucose co-transporter-2 (SGLT2) inhibitor empagliflozin for the treatment of adults with type 2 diabetes (T2D) to the U.S. Food and Drug Administration (FDA).
Targeted therapy with BRAF-MEK inhibitors is an effective treatment for patients with advanced melanoma that cannot be surgically removed or has spread to other areas of the body.
New research asks if medicine is fast becoming a woman's domain. In the UK, female doctors are set to outnumber their male counterparts by 2017, a trend that British press headlines have dubbed "worrying" and "bad for medicine."
› Verified 4 days ago
| Entity Name | Urgent Care Of Muskogee Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1740678622 PECOS PAC ID: 5698090926 Enrollment ID: O20150209001646 |
News Archive
A new Wall Street Journal/NBC survey concludes that more Americans than ever before view the health law as a bad idea. Just as these numbers are rolling out, the White House is launching its own messaging effort - reaching out to Democrats and Republicans, high-ranking officials and lawmakers - to get people to sign up for coverage through the overhaul's new online health insurance exchanges.
Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company today announced the resubmission of a New Drug Application (NDA) for the investigational sodium glucose co-transporter-2 (SGLT2) inhibitor empagliflozin for the treatment of adults with type 2 diabetes (T2D) to the U.S. Food and Drug Administration (FDA).
Targeted therapy with BRAF-MEK inhibitors is an effective treatment for patients with advanced melanoma that cannot be surgically removed or has spread to other areas of the body.
New research asks if medicine is fast becoming a woman's domain. In the UK, female doctors are set to outnumber their male counterparts by 2017, a trend that British press headlines have dubbed "worrying" and "bad for medicine."
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Azhar Shakeel, MD 1145 S. Utica Ave., Suite 110, Tulsa, OK 74104-4013 Ph: (918) 579-3826 | Azhar Shakeel, MD Dewey Bartlett & Main, Henryetta, OK 74023-4101 Ph: (918) 650-1323 |
News Archive
A new Wall Street Journal/NBC survey concludes that more Americans than ever before view the health law as a bad idea. Just as these numbers are rolling out, the White House is launching its own messaging effort - reaching out to Democrats and Republicans, high-ranking officials and lawmakers - to get people to sign up for coverage through the overhaul's new online health insurance exchanges.
Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company today announced the resubmission of a New Drug Application (NDA) for the investigational sodium glucose co-transporter-2 (SGLT2) inhibitor empagliflozin for the treatment of adults with type 2 diabetes (T2D) to the U.S. Food and Drug Administration (FDA).
Targeted therapy with BRAF-MEK inhibitors is an effective treatment for patients with advanced melanoma that cannot be surgically removed or has spread to other areas of the body.
New research asks if medicine is fast becoming a woman's domain. In the UK, female doctors are set to outnumber their male counterparts by 2017, a trend that British press headlines have dubbed "worrying" and "bad for medicine."
› Verified 4 days ago
Wesley E Parkhurst Jr., MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 617 W Trudgeon St, Henryetta, OK 74437 Phone: 918-652-4400 Fax: 918-652-9869 | |
Audie Granville Swinney, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 28870 South Dewey Bartlett Ave, Henryetta, OK 74437 Phone: 918-652-2513 Fax: 918-652-7884 | |
Dr. Michael Terence Cain, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2401 W Main St, Henryetta, OK 74437 Phone: 918-652-9650 Fax: 918-652-7827 | |
Gary D Lovell, D.O. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1102 W Main St, Henryetta, OK 74437 Phone: 918-652-9614 Fax: 918-652-4831 | |
Raffi Djevalikian, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: Dewey Bartlett & Main, Henryetta, OK 74437 Phone: 918-650-1301 Fax: 918-650-0568 |